SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001023024-21-000021
Filing Date
2021-11-01
Accepted
2021-11-01 08:30:37
Documents
77
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q anip-20210930x10q.htm   iXBRL 10-Q 2417848
2 EX-31.1 anip-20210930ex311dd6d8b.htm EX-31.1 11362
3 EX-31.2 anip-20210930ex3129ff7ba.htm EX-31.2 10782
4 EX-32.1 anip-20210930ex32131ac31.htm EX-32.1 8617
  Complete submission text file 0001023024-21-000021.txt   9075887

Data Files

Seq Description Document Type Size
5 EX-101.SCH anip-20210930.xsd EX-101.SCH 48272
6 EX-101.CAL anip-20210930_cal.xml EX-101.CAL 66341
7 EX-101.DEF anip-20210930_def.xml EX-101.DEF 207278
8 EX-101.LAB anip-20210930_lab.xml EX-101.LAB 392429
9 EX-101.PRE anip-20210930_pre.xml EX-101.PRE 390272
10 EXTRACTED XBRL INSTANCE DOCUMENT anip-20210930x10q_htm.xml XML 1859472
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31812 | Film No.: 211365402
SIC: 2834 Pharmaceutical Preparations